{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T08:25:04Z","timestamp":1794212704938,"version":"4.8.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>Persistent chemotherapy-induced alopecia (pCIA) is defined as incomplete hair growth \u22656\u00a0months after chemotherapy completion. This scoping review aimed to identify gaps for future research by mapping pCIA\u2019s incidence, risk factors, quality-of-life (QoL) impacts, presentation, prevention, and management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Thirty-nine articles were included. The most common study type was case reports (12\/39, 30.8%). Only 2\/39 (5.1%) were randomized controlled trials (RCTs). Most studies (27\/39, 69.2%) reported pCIA in patients with breast cancer. Alkylating agents, taxanes, and anthracyclines were most frequently reported to be associated with pCIA. All six studies that evaluated QoL reported that pCIA negatively affected patients\u2019 psychological, functional, and social well-being. Scalp cooling was the only intervention shown to prevent pCIA in four studies. Twenty-one studies reported on interventions for the management of pCIA. Topical minoxidil was reported to improve pCIA in 7 out of 12 studies (58.3%). Low-dose oral minoxidil demonstrated benefit in 7 out of 7 studies (100%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>pCIA\u2019s incidence and risk factors should be prospectively evaluated across cancer types and chemotherapeutic agents. Given pCIA\u2019s significant QoL impacts, RCTs should be conducted to investigate existing and emerging interventions for its prevention and management, and to consider including these interventions in the standard of care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/spc.0000000000000832","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:00:09Z","timestamp":1792224009000},"page":"287-297","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Persistent chemotherapy-induced alopecia: a scoping review"],"prefix":"10.1097","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6388-1548","authenticated-orcid":false,"given":"Amy WS","family":"Lo","sequence":"first","affiliation":[{"name":"Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong S.A.R, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheona SN","family":"Leung","sequence":"additional","affiliation":[{"name":"Department of Oncology, Princess Margaret Hospital, Kowloon West Cluster, Hospital Authority, Hong Kong S.A.R, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1873-6062","authenticated-orcid":false,"given":"Cindy LS","family":"Wong","sequence":"additional","affiliation":[{"name":"Hevel Oncology Centre, Hong Kong S.A.R., China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6150-4550","authenticated-orcid":false,"given":"Jessica","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Oncology, Princess Margaret Hospital, Kowloon West Cluster, Hospital Authority, Hong Kong S.A.R, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azael","family":"Freites-Martinez","sequence":"additional","affiliation":[{"name":"Oncodermatology Clinic, Hospital Ruber Juan Bravo, Madrid, Spain"},{"name":"Facultad de Medicina, Universidad Europea, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9081-0266","authenticated-orcid":false,"given":"Juhee","family":"Cho","sequence":"additional","affiliation":[{"name":"Center for Clinical Epidemiology, Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanam Tabataba","family":"Vakili","sequence":"additional","affiliation":[{"name":"Louise Temerty Breast Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muna","family":"Alkhaifi","sequence":"additional","affiliation":[{"name":"Breast Diagnostics and Cancer Survivorship Care, Department of Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond J","family":"Chan","sequence":"additional","affiliation":[{"name":"Caring Futures Institute, College of Health and Enablement, Flinders University, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Jefford","sequence":"additional","affiliation":[{"name":"Centre for Health Services Research in Cancer, Department of Medical Oncology, and Australian Cancer Survivorship Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia"},{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8670-8514","authenticated-orcid":false,"given":"Jennifer M.","family":"Jones","sequence":"additional","affiliation":[{"name":"Cancer Rehabilitation and Survivorship, Princess Margaret Cancer Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mylin","family":"Torres","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Glenn Family Breast Center, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Lustberg","sequence":"additional","affiliation":[{"name":"Section of Medical Oncology, Department of Medicine, Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Y. Y.","family":"Kwan","sequence":"additional","affiliation":[{"name":"Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada"},{"name":"Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0592-7820","authenticated-orcid":false,"given":"Julie Ryan","family":"Wolf","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Rochester Medical Centre, Rochester, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian W","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, BC Cancer \u2013 Vancouver, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shing Fung","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, National University Cancer Institute, Singapore"},{"name":"Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"van den Hurk","sequence":"additional","affiliation":[{"name":"Catharina Hospital, Eindhoven, The Netherlands"},{"name":"Santeon, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Chow","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry CY","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"R1-20261109","doi-asserted-by":"crossref","first-page":"3609\u20133626","DOI":"10.3390\/curroncol30040275","article-title":"Prevention and treatment of chemotherapy-induced alopecia: what is available and what is coming?","volume":"30","author":"Wikramanayake","year":"2023","journal-title":"Curr Oncol"},{"key":"R2-20261109","article-title":"Persistent chemotherapy-induced alopecia, persistent radiotherapy-induced alopecia, and hair growth disorders related to endocrine therapy or cancer surgery","author":"Azael","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R3-20261109","first-page":"543\u2013549","article-title":"Chemotherapy-induced alopecia: psychosocial impact and therapeutic approaches","volume":"12","author":"Hesketh","year":"2004","journal-title":"Support Care Cancer"},{"key":"R4-20261109","first-page":"1179\u20131196","article-title":"Hair disorders in patients with cancer","volume":"80","author":"Freites-Martinez","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"R5-20261109","first-page":"1235\u20131245","article-title":"Hair loss: alopecia fears and realities for survivors of breast cancer-a narrative review","volume":"13","author":"Peera","year":"2024","journal-title":"Ann Palliat Med"},{"key":"R6-20261109","doi-asserted-by":"crossref","first-page":"631\u2013637","DOI":"10.1016\/j.abd.2020.03.005","article-title":"Scalp cooling to prevent chemotherapy-induced alopecia","volume":"95","author":"Silva","year":"2020","journal-title":"An Bras Dermatol"},{"key":"R7-20261109","first-page":"100096","article-title":"Manual scalp cooling in early-stage breast cancer case report: value of caretaker training and patient experience to optimize efficacy and patient selection","volume":"4","author":"Rezayee","year":"2021","journal-title":"Curr Probl Cancer"},{"key":"R8-20261109","doi-asserted-by":"crossref","first-page":"187\u2013193","DOI":"10.1016\/j.breast.2019.12.004","article-title":"Randomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia","volume":"49","author":"Bajpai","year":"2020","journal-title":"Breast"},{"key":"R9-20261109","doi-asserted-by":"crossref","first-page":"3115\u20133122","DOI":"10.1200\/JCO.23.02374","article-title":"Scalp cooling in preventing persistent chemotherapy-induced alopecia: a randomized controlled trial","volume":"42","author":"Kang","year":"2024","journal-title":"J Clin Oncol"},{"key":"R10-20261109","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s00403-023-02810-3","article-title":"Expanding access to scalp cooling therapy: a review of scalp cooling outcomes in patients who received financial assistance from a nonprofit organization","volume":"316","author":"Novice","year":"2024","journal-title":"Arch Dermatol Res"},{"key":"R11-20261109","doi-asserted-by":"crossref","first-page":"2777\u20132786","DOI":"10.2147\/DDDT.S214907","article-title":"Minoxidil and its use in hair disorders: a review","volume":"13","author":"Suchonwanit","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"R12-20261109","doi-asserted-by":"crossref","first-page":"987\u2013991","DOI":"10.1001\/jamadermatol.2020.1867","article-title":"Association between ABCB1 genetic variants and persistent chemotherapy-induced alopecia in women with breast cancer","volume":"156","author":"Nunez-torres","year":"2020","journal-title":"JAMA Dermatol"},{"key":"R13-20261109","first-page":"627\u2013634","article-title":"Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling","volume":"171","author":"Martin","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"R14-20261109","first-page":"6119\u20136125","article-title":"Prospective study of hair recovery after (neo)adjuvant chemotherapy with scalp cooling in Japanese breast cancer patients","volume":"29","author":"Ohsumi","year":"2021","journal-title":"Support Care Cancer"},{"key":"R15-20261109","doi-asserted-by":"crossref","first-page":"e0208118","DOI":"10.1371\/journal.pone.0208118","article-title":"A multicenter survey of temporal changes in chemotherapy-induced hair loss in breast cancer patients","volume":"14","author":"Watanabe","year":"2019","journal-title":"PLoS One"},{"key":"R16-20261109","doi-asserted-by":"crossref","first-page":"593\u2013597","DOI":"10.1038\/sj.bmt.1703695","article-title":"Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy","volume":"30","author":"de Jonge","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"R17-20261109","doi-asserted-by":"crossref","first-page":"499\u2013505","DOI":"10.1016\/j.jaad.2013.10.034","article-title":"Clinical characteristics of chemotherapy-induced alopecia in childhood","volume":"70","author":"Choi","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"R18-20261109","doi-asserted-by":"crossref","first-page":"984\u2013988","DOI":"10.1038\/bmt.2017.15","article-title":"Permanent diffuse alopecia after haematopoietic stem cell transplantation in childhood","volume":"52","author":"Bresters","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"R19-20261109","first-page":"1829\u20131837","article-title":"Impact of a topical lotion, CG428, on permanent chemotherapy-induced alopecia in breast cancer survivors: a pilot randomized double-blind controlled clinical trial (VOLUME RCT)","volume":"28","author":"Kang","year":"2020","journal-title":"Support Care Cancer"},{"key":"R20-20261109","doi-asserted-by":"crossref","first-page":"414\u2013420","DOI":"10.1634\/theoncologist.2018-0184","article-title":"Permanent chemotherapy-induced alopecia in patients with breast cancer: a 3-year prospective cohort study","volume":"24","author":"Kang","year":"2019","journal-title":"Oncologist"},{"key":"R21-20261109","first-page":"e13395","article-title":"Permanent hair loss associated with taxane chemotherapy use in breast cancer: a retrospective survey at two tertiary UK cancer centres","volume":"30","author":"Chan","year":"2021","journal-title":"Eur J Cancer Care (Engl)"},{"key":"R22-20261109","doi-asserted-by":"crossref","first-page":"e31432","DOI":"10.1002\/pbc.31432","article-title":"Impact of persistent alopecia on quality of life in childhood cancer and transplant survivors","volume":"72","author":"Kim","year":"2025","journal-title":"Pediatr Blood Cancer"},{"key":"R23-20261109","doi-asserted-by":"crossref","first-page":"1004\u20131007","DOI":"10.1111\/pde.15907","article-title":"Pediatric ewing\u2019s sarcoma and permanent chemotherapy-induced alopecia: a case-control study","volume":"42","author":"Lillich","year":"2025","journal-title":"Pediatr Dermatol"},{"key":"R24-20261109","doi-asserted-by":"crossref","first-page":"869\u2013887","DOI":"10.1007\/s13555-025-01378-2","article-title":"Defining predictive factors for permanent chemotherapy-induced alopecia: trichoscopy, reflectance confocal microscopy and histopathology study on 77 patients","volume":"15","author":"Starace","year":"2025","journal-title":"Dermatol Ther (Heidelb)"},{"key":"R25-20261109","doi-asserted-by":"crossref","first-page":"527\u2013533","DOI":"10.1007\/s10549-017-4204-x","article-title":"Chemotherapy-induced irreversible alopecia in early breast cancer patients","volume":"163","author":"Kim","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"R26-20261109","doi-asserted-by":"crossref","first-page":"1335\u20131342","DOI":"10.1001\/jamadermatol.2021.3676","article-title":"Clinicopathologic characteristics and response to treatment of persistent chemotherapy-induced alopecia in breast cancer survivors","volume":"157","author":"Bhoyrul","year":"2021","journal-title":"JAMA Dermatol"},{"key":"R27-20261109","doi-asserted-by":"crossref","first-page":"724\u2013728","DOI":"10.1001\/jamadermatol.2018.5071","article-title":"Assessment of quality of life and treatment outcomes of patients with persistent postchemotherapy alopecia","volume":"155","author":"Freites-Martinez","year":"2019","journal-title":"JAMA Dermatol"},{"key":"R28-20261109","doi-asserted-by":"crossref","first-page":"2879\u20132884","DOI":"10.1093\/annonc\/mds095","article-title":"Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil\/epirubicin\/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients","volume":"23","author":"Kluger","year":"2012","journal-title":"Ann Oncol"},{"key":"R29-20261109","first-page":"483\u2013489","article-title":"Madarosis: a qualitative study to assess perceptions and experience of Australian patients with early breast cancer treated with taxane-based chemotherapy","volume":"26","author":"Smith","year":"2018","journal-title":"Support Care Cancer"},{"key":"R30-20261109","doi-asserted-by":"crossref","first-page":"395\u2013400","DOI":"10.1007\/s10549-016-3799-7","article-title":"Cold thermal injury from cold caps used for the prevention of chemotherapy-induced alopecia","volume":"157","author":"Belum","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"R31-20261109","article-title":"Persistent chemotherapy-induced alopecia treated with low dose oral minoxidil: a multicenter retrospective case series of 15 patients","volume":"13","author":"Iorizzo","year":"2023","journal-title":"Dermatol Pract Concept"},{"key":"R32-20261109","doi-asserted-by":"crossref","first-page":"e15165","DOI":"10.1016\/j.heliyon.2023.e15165","article-title":"Treatment of persistent chemotherapy-induced hair loss (Alopecia) with human mesenchymal stromal cells exosome enriched extracellular vesicles: a case report","volume":"9","author":"Norooznezhad","year":"2023","journal-title":"Heliyon"},{"key":"R33-20261109","first-page":"3270\u20133279","article-title":"Evaluation of efficacy of QR678((R)) and QR678((R)) Neo hair growth factor formulation in the treatment of persistent chemotherapy-induced alopecia caused due to cytotoxic chemotherapy-A prospective pilot study","volume":"19","author":"Kapoor","year":"2020","journal-title":"J Cosmet Dermatol"},{"key":"R34-20261109","first-page":"186","article-title":"Hair loss during and after breast cancer therapy","volume":"31","author":"Rose","year":"2023","journal-title":"Support Care Cancer"},{"key":"R35-20261109","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2026.01.042","article-title":"Radiation-induced alopecia in patients undergoing intracranial radiation therapy: a systematic review","author":"Jafari","year":"2026","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R36-20261109","doi-asserted-by":"crossref","first-page":"55\u201361","DOI":"10.2310\/7750.2012.12033","article-title":"Radiation- and chemotherapy-induced permanent alopecia: case series","volume":"17","author":"Haider","year":"2013","journal-title":"J Cutan Med Surg"},{"key":"R37-20261109","doi-asserted-by":"crossref","first-page":"635\u2013637","DOI":"10.1016\/j.abd.2023.07.010","article-title":"Low-dose oral minoxidil for persistent chemotherapy and radiotherapy-induced alopecia in a pediatric female patient","volume":"99","author":"Melo","year":"2024","journal-title":"An Bras Dermatol"},{"key":"R38-20261109","article-title":"Effectiveness of scalp cooling to prevent chemotherapy-induced alopecia in patients undergoing breast cancer treatment: a systematic review and meta-analysis","volume":"47","author":"Miguel","year":"2024","journal-title":"Cancer Nurs"},{"key":"R39-20261109","first-page":"5090\u20135103","article-title":"Efficacy of scalp cooling for prevention of chemotherapy induced alopecia: a systematic review and meta-analysis","volume":"25","author":"Shen","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R40-20261109","first-page":"8349\u20138355","article-title":"Factors influencing scalp cooling discussions and use at a large academic institution: a single-center retrospective review","volume":"30","author":"Novice","year":"2022","journal-title":"Support Care Cancer"},{"key":"R41-20261109","doi-asserted-by":"crossref","first-page":"186\u2013194","DOI":"10.1111\/j.1365-2133.2004.05785.x","article-title":"Minoxidil: mechanisms of action on hair growth","volume":"150","author":"Messenger","year":"2004","journal-title":"Br J Dermatol"},{"key":"R42-20261109","doi-asserted-by":"crossref","first-page":"2039\u20132046","DOI":"10.1111\/jdv.70021","article-title":"Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopecia","volume":"39","author":"Freites-Martinez","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R43-20261109","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.3390\/jcm14061805","article-title":"Characterization and management of adverse events of low-dose oral minoxidil treatment for alopecia: a narrative review","volume":"14","author":"Jimenez-cauhe","year":"2025","journal-title":"J Clin Med"}],"container-title":["Current Opinion in Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/SPC.0000000000000832","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T08:00:29Z","timestamp":1794211229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/SPC.0000000000000832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/spc.0000000000000832","relation":{},"ISSN":["1751-4266","1751-4258"],"issn-type":[{"value":"1751-4266","type":"electronic"},{"value":"1751-4258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,16]]}}}